- Stocks
- Healthcare
- NASDAQ: ALBT

Price (delayed)

$0.282

Market cap

$3.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.41

Enterprise value

$11.24M

The revenue has contracted by 24% from the previous quarter but it has grown by 6% YoY

The net income has decreased by 17% YoY but it has increased by 11% from the previous quarter

Avalon GloboCare's gross margin has shrunk by 140% QoQ and by 25% YoY

Avalon GloboCare's gross profit has plunged by 131% from the previous quarter and by 32% YoY

What are the main financial stats of ALBT

Market
Valuations
Earnings

Shares outstanding

11.1M

Market cap

$3.13M

Enterprise value

$11.24M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.51

Price to sales (P/S)

3.24

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

11.72

Revenue

$959,516

EBIT

-$13.24M

EBITDA

-$12.93M

Free cash flow

-$5.59M

Per share
Balance sheet
Liquidity

EPS

-$1.41

Free cash flow per share

-$0.51

Book value per share

$0.55

Revenue per share

$0.09

TBVPS

$1.84

Total assets

$20.33M

Total liabilities

$14.28M

Debt

$8.42M

Equity

$6.05M

Working capital

-$7.03M

Debt to equity

1.39

Current ratio

0.1

Quick ratio

0.05

Net debt/EBITDA

-0.63

Margins
Efficiency
Dividend

EBITDA margin

-1,347.4%

Gross margin

-7.6%

Net margin

-1,558.2%

Operating margin

-1,484.8%

Return on assets

-58.9%

Return on equity

-123.6%

Return on invested capital

-50.3%

Return on capital employed

-105.6%

Return on sales

-1,379.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Avalon GloboCare stock price performed over time

Intraday

-11.88%

1 week

-29.5%

1 month

-35.91%

1 year

-78.31%

YTD

-41.61%

QTD

-40%

How have Avalon GloboCare's revenue and profit performed over time

Revenue

$959,516

Gross profit

-$72,658

Operating income

-$14.25M

Net income

-$14.95M

Gross margin

-7.6%

Net margin

-1,558.2%

Avalon GloboCare's gross margin has shrunk by 140% QoQ and by 25% YoY

Avalon GloboCare's gross profit has plunged by 131% from the previous quarter and by 32% YoY

ALBT's operating income is down by 47% year-on-year but it is up by 10% since the previous quarter

ALBT's operating margin is down by 38% year-on-year and by 18% since the previous quarter

What is Avalon GloboCare's growth rate over time

What is Avalon GloboCare stock price valuation

P/E

N/A

P/B

0.51

P/S

3.24

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

11.72

The EPS has grown by 11% since the previous quarter but it has declined by 7% year-on-year

The stock's price to book (P/B) is 98% less than its 5-year quarterly average of 30.4 and 16% less than its last 4 quarters average of 0.7

The equity has dropped by 70% year-on-year and by 18% since the previous quarter

The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 50.4 and 56% less than its last 4 quarters average of 8.5

The revenue has contracted by 24% from the previous quarter but it has grown by 6% YoY

How efficient is Avalon GloboCare business performance

The return on sales has declined by 37% year-on-year and by 13% since the previous quarter

ALBT's return on assets is up by 15% year-on-year

ALBT's return on equity is down by 15% since the previous quarter but it is up by 13% year-on-year

ALBT's ROIC is up by 11% YoY and by 6% QoQ

What is ALBT's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ALBT.

How did Avalon GloboCare financials performed over time

The company's total assets is 42% higher than its total liabilities

Avalon GloboCare's quick ratio has shrunk by 75% YoY and by 29% QoQ

The current ratio has dropped by 63% year-on-year and by 23% since the previous quarter

The company's debt is 39% higher than its equity

The equity has dropped by 70% year-on-year and by 18% since the previous quarter

The company's debt has surged by 51% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.